Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05224154 · ClinicalTrials.gov registry record · NA
Re-Connect Application for Smoking Cessation
A NA study of Smoking Cessation and Acceptability of Health Care, sponsored by Rowan University.
- Recruiting
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT05224154: Recruiting NA study of Smoking Cessation and Acceptability of Health Care, sponsored by Rowan University.
NCT05224154 is a NA study of Smoking Cessation and Acceptability of Health Care that is actively recruiting participants, run by Rowan University. The registered enrollment target is 82 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05224154, a NA study of Smoking Cessation and Acceptability of Health Care, is actively recruiting participants, sponsored by Rowan University.
- RECRUITING
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.
Primary Outcome
A survey that participants in Aim 1 usability testing will complete after testing out the Re-Connect application. Focus and feedback group participants, as well as single-case design participants, will complete this survey and a score of 75 or higher will be required before moving to the RCT in Aim 2.
Conditions Studied
Interventions
- BEHAVIORAL Abstinent Contingent (AC) Re-Connect
- BEHAVIORAL Submission Contingent (SC) Re-Connect
Study Locations (1)
New Jersey
- Rowan University - Glassboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2021-12-14 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT05224154 shows while recruiting
NCT05224154 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Abstinent Contingent (AC) Re-Connect is the first listed.
NCT05224154 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05224154 about?
NCT05224154 is a clinical study titled "Re-Connect Application for Smoking Cessation". This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.
What is the current status of trial NCT05224154?
This trial is currently recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2021-12-14. Estimated completion is 2026-03-31.
What conditions does trial NCT05224154 study?
This clinical trial studies the following conditions: Smoking Cessation, Acceptability of Health Care, Nicotine Dependence, Cigarettes.
What interventions are being tested in trial NCT05224154?
The interventions under investigation include: Abstinent Contingent (AC) Re-Connect (BEHAVIORAL), Submission Contingent (SC) Re-Connect (BEHAVIORAL).
Who is sponsoring clinical trial NCT05224154?
This trial is sponsored by Rowan University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05224154 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05224154's enrollment target sits among peer trials
82 125th of 188 higher than 64 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI